Price $2.56 |
Market Cap
394.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
-
|
P/S
3.33
|
Dividend %
-
|
|
P/CF
4.2
|
P/FCF
-
|
Op. Cash Flow
-14.3K
|
FCF
-0.3
|
|
Op. Margin
-48.50%
|
Net Margin
-75.80%
|
ROE
65.60%
|
ROI
84.50%
|
|
ROA
-54.10%
|
EPS Growth
50.20%
|
Current Ratio
1.1
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| CYANOTECH CORP (CYAN) | $2.60 | - | - | 18.3M | Strong Buy |
| MTBC Inc (MTBC) | $4.81 | - | - | 58.3M | Strong Buy |
| Natus Medical Inc (BABY) | $26.07 | - | - | 838.9M | Strong Buy |
| Neurometrix Inc (NURO) | $0.43 | - | - | 4.6M | Strong Buy |
| Novelion Therapeutics Inc (USA (NVLN) | $0.71 | - | - | 15.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
